Stocks & Investing
Tue, September 10, 2024
[ Tue, Sep 10th 2024
] - WOPRAI
Thu, August 15, 2024
[ Thu, Aug 15th 2024
] - WOPRAI
Tue, August 13, 2024
[ Tue, Aug 13th 2024
] - WOPRAI
Tue, June 18, 2024
[ Tue, Jun 18th 2024
] - WOPRAI
Thu, June 6, 2024
[ Thu, Jun 06th 2024
] - WOPRAI
Fri, May 10, 2024
[ Fri, May 10th 2024
] - WOPRAI
Mon, April 1, 2024
[ Mon, Apr 01st 2024
] - WOPRAI
[ Mon, Apr 01st 2024
] - WOPRAI
Tue, March 19, 2024
[ Tue, Mar 19th 2024
] - WOPRAI
Tue, March 12, 2024
[ Tue, Mar 12th 2024
] - WOPRAI
Wed, February 21, 2024
Mon, February 12, 2024
Wed, July 5, 2023
[ Wed, Jul 05th 2023
] - WOPRAI
Fri, May 19, 2023
[ Fri, May 19th 2023
] - WOPRAI
Thu, March 30, 2023
[ Thu, Mar 30th 2023
] - WOPRAI
Fri, March 24, 2023
[ Fri, Mar 24th 2023
] - WOPRAI
Fri, January 27, 2023
[ Fri, Jan 27th 2023
] - WOPRAI
Mon, September 12, 2022
[ Mon, Sep 12th 2022
] - WOPRAI
Tue, August 16, 2022
[ Tue, Aug 16th 2022
] - WOPRAI
Tue, February 1, 2022
[ Tue, Feb 01st 2022
] - WOPRAI
Jeff Jones Reiterated (avbp) at Buy with Increased Target to $39 on, Sep 10th, 2024
Jeff Jones of Oppenheimer, Reiterated "ArriVent BioPharma, Inc." (AVBP) at Buy with Increased Target from $35 to $39 on, Sep 10th, 2024.
Jeff, nor any peers, have made any analyst calls on AVBP in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30